Clinical Trial Protocol & Regulatory Submission Assistant
Draft ICH-GCP compliant clinical trial protocols and regulatory submissions
What You Can Do
With this skill, you can generate comprehensive clinical trial protocols, safety documentation, and eCTD submissions that meet ICH-GCP E6(R2), FDA, and EMA standards. You'll automate the creation of detailed protocol sections, informed consent forms, and regulatory modules, ensuring consistency with current guidelines and reducing cycles needed for agency review.
Features
Automatically validates protocol content against ICH-GCP E6(R2) principles, flagging missing sections and non-compliant language before regulatory submission
Creates complete study protocols for Phase I-IV trials with all required sections: objectives, endpoints, statistical analysis plans, inclusion/exclusion criteria, safety monitoring, and data management
Generates adverse event summaries, expedited safety reports, Data Safety Monitoring Board briefings, and quality overall summaries with proper data integration and causality assessment
Formats submissions in eCTD XML structure (CTD Module 2 and beyond) with proper cross-references, section numbering, and regulatory module hierarchy for FDA, EMA, and PMDA review
Drafts patient-friendly ICFs with risk/benefit summaries, data protection notices (GDPR/HIPAA compliant), and comprehension-tested language at 6-8th grade reading level
Produces comprehensive SAPs including population definitions, primary/secondary efficacy and safety endpoints, statistical methods, analysis sets, and interim analysis frameworks
Develops ICH-Q9 aligned risk assessments covering chemistry, manufacturing, use, adverse event risks, and mitigation strategies with FMEA-style prioritization
Provides phase-specific submission checklists for IND, CTA, NDA, BLA, and annual safety updates to ensure no required documents or data are omitted
Example Output
Protocol Section Output:
## 4.2 Study Objectives and Endpoints
### Primary Objectives
- Evaluate efficacy of Drug X 150mg daily vs. placebo in reducing Pain Score at Week 12
- Non-inferiority margin: -2.5 points (primary endpoint: change from baseline)
### Secondary Objectives
- Assess safety/tolerability via AE monitoring and lab values
- Evaluate PK/PD relationship using population pharmacokinetic analysis
eCTD Module 2.7.5 (Clinical Summary of Efficacy) Excerpt:
2.7.5.1 Clinical Summary of Efficacy
2.7.5.1.1 Summary of Efficacy Data
2.7.5.1.2 Comparative Efficacy
2.7.5.1.3 Efficacy in Special Populations
2.7.5.2 Conclusions on Clinical Efficacy
Safety Report Example:
Serious Adverse Events Summary (Reporting Period Q1 2026)
- Total SAEs: 8 in Drug X vs. 2 in placebo (n=250 each)
- Causality: 6 related, 1 unrelated, 1 unknown
- Most Frequent: Elevated transaminases (Grade 2-3, 4 subjects)
- Recommendation: Continue with hepatic monitoring per protocol amendment
What's Included
- Phase-Specific Protocol Templates: Pre-formatted protocol templates for Phase I (FIH), Phase II, Phase IIb, Phase III, and Phase IV trials with all required ICH-GCP sections
- eCTD Submission Framework: Complete CTD Module 2 (Summaries) and Module 5 (Clinical Study Reports) structure with XML formatting guidance and cross-reference templates
- Safety Documentation Library: Templates for annual safety reports, interim safety analyses, expedited reporting documents, DSMB briefing books, and safety update letters
- Informed Consent Form Suite: Patient-friendly ICF templates for multiple therapeutic areas with risk/benefit tables, comprehension checks, and data protection notices (GDPR/HIPAA/PIPEDA)
- ICH-GCP E6(R2) Reference Guide: Quick-reference checklist mapping all 13 GCP principles to protocol sections, with examples of compliant language and documentation requirements
- Regulatory Submission Checklists: Jurisdiction-specific submission checklists for FDA (IND/NDA/BLA), EMA (CTA/MAA), PMDA (IND-J/NDA), and Health Canada submissions
Who It's For
- Clinical Research Associates and CRO Project Managers
- Regulatory Affairs Specialists and Managers
- Medical Writers and Technical Authors
- Clinical Trial Sponsors (Biotech, Pharma, Medical Device companies)
- Clinical Operations and Data Management Leaders
Best For
- Drafting and revising clinical trial study protocols (Phase I-IV)
- Preparing regulatory submissions (IND, NDA, BLA, CTA, MAA applications)
- Creating safety reports, adverse event summaries, and DSMB documents
- Generating patient-friendly informed consent forms and informed consent narratives
- Developing statistical analysis plans and quality risk assessments
You might also like
You can automate the creation of comprehensive, regulatory-compliant Statistical Analysis Plans (SAPs) for clinical trials. The skill generates complete SAP documents with FDA/ICH-aligned sections, performs compliance validation, optimizes statistical methodologies, and ensures consistency with trial protocols—reducing SAP development time from weeks to days.
by hah23255
You structure clinical research manuscripts according to IMRaD (Introduction, Methods, Results, Discussion) standards required by peer-reviewed journals. This skill helps you draft sections from raw research notes, polish prose for academic clarity, enforce citation standards, and identify common submission issues before sending to journals. The result is a manuscript ready for peer review with minimal editor feedback.
by hah23255
You'll design and optimize observational study protocols from conception through regulatory documentation. The skill guides you through identifying and quantifying confounders, selecting appropriate study designs (cohort, case-control, cross-sectional), implementing bias mitigation strategies, and generating publication-ready protocols that meet regulatory standards.
by hah23255
You'll compose regulatory submission documents like Common Technical Documents (CTD), Periodic Safety Updates (PSUR), and Quality Overall Summaries with built-in FDA, EMA, and ICH compliance checks. This skill accelerates document drafting by applying structured templates aligned with regulatory guidelines, reducing revision cycles and ensuring professional-quality submissions. Every generated module is validated for completeness, consistency, and traceability across related sections.
by hah23255
You can systematically review research protocols against ethical frameworks, regulatory standards, and risk-benefit principles. This skill identifies compliance gaps, assesses risks to human or animal subjects, evaluates scientific merit against potential harms, and generates structured compliance reports that support institutional review board (IRB) decisions and regulatory submissions.
by hah23255
You'll structure promotional materials for medical devices and pharmaceuticals that meet regulatory requirements while maintaining persuasive appeal. This framework helps you balance evidence-based claims, risk/benefit communication, and targeted messaging for different audiences—ensuring your materials are compliant, defensible, and effective.
by hah23255
Create comprehensive data governance policies, compliance frameworks, and access control matrices tailored to healthcare research regulations. Audit existing data management practices against HIPAA, GDPR, and institutional requirements, identify gaps, and generate actionable remediation plans with detailed documentation and risk assessments.
by hah23255
You can design, validate, and execute statistical analyses for health outcomes research, comparative effectiveness studies, and clinical trials with regulatory rigor. This skill guides you through study design validation, appropriate statistical method selection, data quality assessment, hypothesis testing, and results interpretation aligned with FDA, EMA, and ICH-GCP standards. You'll generate publication-ready analysis plans and ensure your findings meet scientific and regulatory requirements for peer review or submission.
by hah23255